share_log

明德生物(002932.SZ)已累计回购3.59%股份 耗资约1.63亿元

Wuhan Easy Diagnosis Biomedicine (002932.SZ) has accumulated a repurchase of 3.59% of its shares, with a total cost of approximately 163 million yuan.

Zhitong Finance ·  Jul 1 19:29

Wuhan Easy Diagnosis Biomedicine (002932.SZ) announces that as of June 30, 2024, the company has repurchased through a repurchase special securities account...

According to the announcement of Wuhan Easy Diagnosis Biomedicine (002932.SZ) on the Zhijun Finance APP, as of June 30, 2024, the company has repurchased a total of 8.3497 million shares of the company's stock through a repurchase special securities account by means of concentrated bidding, accounting for 3.59% of the company's total share capital. The highest fill price of repurchased shares was 20.98 yuan/share, the lowest fill price was 18.17 yuan/share, and the total transaction amount was 163 million yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment